154 related articles for article (PubMed ID: 23449001)
1. Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder.
Soeiro-de-Souza MG; Andreazza AC; Carvalho AF; Machado-Vieira R; Young LT; Moreno RA
Int J Neuropsychopharmacol; 2013 Aug; 16(7):1505-12. PubMed ID: 23449001
[TBL] [Abstract][Full Text] [Related]
2. Decreased global methylation in patients with bipolar disorder who respond to lithium.
Huzayyin AA; Andreazza AC; Turecki G; Cruceanu C; Rouleau GA; Alda M; Young LT
Int J Neuropsychopharmacol; 2014 Apr; 17(4):561-9. PubMed ID: 24345589
[TBL] [Abstract][Full Text] [Related]
3. DNA redox modulations and global DNA methylation in bipolar disorder: Effects of sex, smoking and illness state.
Ceylan D; Scola G; Tunca Z; Isaacs-Trepanier C; Can G; Andreazza AC; Young LT; Özerdem A
Psychiatry Res; 2018 Mar; 261():589-596. PubMed ID: 29407727
[TBL] [Abstract][Full Text] [Related]
4. A comparative meta-analysis of peripheral 8-hydroxy-2'-deoxyguanosine (8-OHdG) or 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG) levels across mood episodes in bipolar disorder.
Çeli K HEA; Tuna G; Ceylan D; Küçükgöncü S
Psychoneuroendocrinology; 2023 May; 151():106078. PubMed ID: 36931055
[TBL] [Abstract][Full Text] [Related]
5. Increased DNA and RNA damage by oxidation in patients with bipolar I disorder.
Jacoby AS; Vinberg M; Poulsen HE; Kessing LV; Munkholm K
Transl Psychiatry; 2016 Aug; 6(8):e867. PubMed ID: 27505230
[TBL] [Abstract][Full Text] [Related]
6. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.
Cunha AB; Frey BN; Andreazza AC; Goi JD; Rosa AR; Gonçalves CA; Santin A; Kapczinski F
Neurosci Lett; 2006 May; 398(3):215-9. PubMed ID: 16480819
[TBL] [Abstract][Full Text] [Related]
7. Is depression associated with increased oxidative stress? A systematic review and meta-analysis.
Black CN; Bot M; Scheffer PG; Cuijpers P; Penninx BW
Psychoneuroendocrinology; 2015 Jan; 51():164-75. PubMed ID: 25462890
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder.
Chang CC; Jou SH; Lin TT; Liu CS
Psychiatry Clin Neurosci; 2014 Jul; 68(7):551-7. PubMed ID: 24447331
[TBL] [Abstract][Full Text] [Related]
9. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.
Dias VV; Brissos S; Frey BN; Andreazza AC; Cardoso C; Kapczinski F
Bipolar Disord; 2009 Sep; 11(6):663-71. PubMed ID: 19689509
[TBL] [Abstract][Full Text] [Related]
10. Oxidative imbalance in bipolar disorder subtypes: a comparative study.
Yumru M; Savas HA; Kalenderoglu A; Bulut M; Celik H; Erel O
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1070-4. PubMed ID: 19527764
[TBL] [Abstract][Full Text] [Related]
11. Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.
Kikuchi A; Takeda A; Onodera H; Kimpara T; Hisanaga K; Sato N; Nunomura A; Castellani RJ; Perry G; Smith MA; Itoyama Y
Neurobiol Dis; 2002 Mar; 9(2):244-8. PubMed ID: 11895375
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes.
Savas HA; Gergerlioglu HS; Armutcu F; Herken H; Yilmaz HR; Kocoglu E; Selek S; Tutkun H; Zoroglu SS; Akyol O
World J Biol Psychiatry; 2006; 7(1):51-5. PubMed ID: 16428220
[TBL] [Abstract][Full Text] [Related]
13. Serum S100B and antioxidant enzymes in bipolar patients.
Andreazza AC; Cassini C; Rosa AR; Leite MC; de Almeida LM; Nardin P; Cunha AB; Ceresér KM; Santin A; Gottfried C; Salvador M; Kapczinski F; Gonçalves CA
J Psychiatr Res; 2007 Sep; 41(6):523-9. PubMed ID: 16956621
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte mitochondrial DNA copy number in bipolar disorder.
de Sousa RT; Uno M; Zanetti MV; Shinjo SM; Busatto GF; Gattaz WF; Marie SK; Machado-Vieira R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():32-5. PubMed ID: 24036318
[TBL] [Abstract][Full Text] [Related]
15. Peripheral oxidative biomarkers constitute a valuable indicator of the severity of oxidative brain damage in acute cerebral infarction.
Liu H; Uno M; Kitazato KT; Suzue A; Manabe S; Yamasaki H; Shono M; Nagahiro S
Brain Res; 2004 Oct; 1025(1-2):43-50. PubMed ID: 15464743
[TBL] [Abstract][Full Text] [Related]
16. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report.
Frey BN; Andreazza AC; Kunz M; Gomes FA; Quevedo J; Salvador M; Gonçalves CA; Kapczinski F
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):283-5. PubMed ID: 16859818
[TBL] [Abstract][Full Text] [Related]
17. May oxytocin be a trait marker for bipolar disorder?
Turan T; Uysal C; Asdemir A; Kılıç E
Psychoneuroendocrinology; 2013 Dec; 38(12):2890-6. PubMed ID: 24080188
[TBL] [Abstract][Full Text] [Related]
18. Relationship among oxidative stress, DNA damage, and proliferative capacity in human corneal endothelium.
Joyce NC; Zhu CC; Harris DL
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2116-22. PubMed ID: 19117931
[TBL] [Abstract][Full Text] [Related]
19. Defective nitric oxide-cyclic guanosine monophosphate signaling in patients with bipolar disorder: a potential role for platelet dysfunction.
Fontoura PC; Pinto VL; Matsuura C; Resende Ade C; de Bem GF; Ferraz MR; Cheniaux E; Brunini TM; Mendes-Ribeiro AC
Psychosom Med; 2012 Oct; 74(8):873-7. PubMed ID: 23023680
[TBL] [Abstract][Full Text] [Related]
20. Oxidative DNA damage is associated with inflammatory response, insulin resistance and microvascular complications in type 2 diabetes.
Tatsch E; De Carvalho JA; Hausen BS; Bollick YS; Torbitz VD; Duarte T; Scolari R; Duarte MM; Londero SW; Vaucher RA; Premaor MO; Comim FV; Moresco RN
Mutat Res; 2015 Dec; 782():17-22. PubMed ID: 26520687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]